Загрузка...
Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review
Mantle cell lymphoma (MCL) accounts for about 5% of all lymphomas. Its clinical and histological features are heterogeneous. After a frequently good initial response, the disease generally and repeatedly relapses and finally the outcome is poor. Particularly severe is the prognosis of the rare occur...
Сохранить в:
| Опубликовано в: : | Case Rep Hematol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5534293/ https://ncbi.nlm.nih.gov/pubmed/28791187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9583257 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|